Biophytis - ADR

-0.04 (-3.70%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Biophytis - ADR Stock, NASDAQ:BPTS

Sorbonne Universit?©, B?¢timent A 4 ??me ?©tage, Paris, Ile-de-France 75005
Phone: +
Number of Employees: 26


Biophytis SA operates as a clinical-stage biotechnology company. It specializes in the development of therapeutics that are aimed at slowing the degenerative processes associated with aging, including severe respiratory failure in patients suffering from COVID-19. Its products include Sarconeos (BIO101), which is used to treat sarcopenic obesity and Macuneos (BIO201), which is used to treat dry age-related macular degeneration (AMD). The company was founded by Stanislas Veillet and Ren?© Lafont on September 15, 2006 and is headquartered in Paris, France.